Charter Medical Receives FDA 510(k) Clearance For Next Generation CELL FREEZE(R) Cryogenic Stem Cell Storage Containers
MANCHESTER, Conn., Dec. 20, 2010 (GLOBE NEWSWIRE) -- Charter Medical, a subsidiary of Lydall, Inc. (NYSE:LDL) announced today that it has received 510(k) clearance on its next generation Cell Freeze ® Cryogenic Storage Containers for Hematopoietic Progenitor Cells (HPC's). The issuance of the clearance by the U.S. Food and Drug Administration (FDA) allows Charter Medical to begin marketing the newly designed and expanded product offering for cryogenic storage, preservation, and transfer of HPC's. This next generation of containers offers a broader size range from 50 mL to 750 mL, redesigned configuration for easier use, and the same unique film as its predecessor product.
Joe Petrosky, Vice President of Global Marketing and Sales for Charter Medical, stated, "We are excited with this new product as it completes our freezing container platform which serves several high growth markets spanning from medical to cellular therapy and to bio / pharma processing."
Dale Barnhart, CEO of Lydall, stated, "I am pleased with the rapid deployment of this new product which was designed side by side with our customers. It demonstrates our commitment to being the supplier of choice as we grow our presence in these important life sciences markets."About Lydall, Inc. Lydall, Inc. is a New York Stock Exchange listed company, headquartered in Manchester, Connecticut. The Company, with operations in the U.S., France, the Netherlands and Germany and sales offices in the U.S., Europe, and Asia, manufactures specialty engineered products for the thermal/acoustical and filtration/separation markets. For more information, visit http://www.lydall.com . Lydall ® is a registered trademark of Lydall, Inc. in the U.S. and other countries. All product names are trademarks of Lydall, Inc. or Charter Medical, Ltd.
CONTACT: Charter Medical Peggy Niston, Global Product Manager (336) 768-6447 Fax: (336) 774-1750 email@example.com www.chartermedical.com 3948-A Westpoint Blvd Winston-Salem, NC 27103 Lydall, Inc. Peter M. Kurto, Vice President Business Development & Investor Relations 860-646-1233 Fax: 860-646-4917 firstname.lastname@example.org www.lydall.com
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV